A61P 33 - Antiparasitic agents

Patents for A61P 33 - Antiparasitic agents (21,787)
11/1997
11/25/1997	US5691186 Filariid cysteine protease genes
11/25/1997	US5690941 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum at the sporozoite stage and in the hepatocytes
11/25/1997	CA2113567C Benzimidazole anthelmintics
11/20/1997	WO1997042971A1 Recombinant neospora antigens and their uses
11/20/1997	WO1997042969A1 USE OF IL-12 AND IFN-α FOR THE TREATMENT OF INFECTIOUS DISEASES
11/20/1997	WO1997035538A3 Tumor necrosis factor alpha convertase
11/20/1997	CA2251547A1 Recombinant neospora antigens and their uses
11/19/1997	CN1165471A Antiparasitic composition for treating and protecting pets
11/18/1997	US5688513 Immunology with polypeptides against eimeria and coccidiosis
11/13/1997	WO1997042325A1 B. burgdorferi polypeptides expressed in vivo
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253834A1 B. burgdorferi polypeptides expressed in vivo
11/12/1997	EP0805795A1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides
11/11/1997	US5686080 Parasitic helminth p4 proteins
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040826A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
11/06/1997	CA2252492A1 Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
11/05/1997	EP0804929A2 Treatment of schistosomiasis
11/05/1997	EP0804581A1 Compounds and methods for the stimulation and enhancement of protective immune responses and il-12 production
11/05/1997	EP0804552A1 Redirection of cellular immunity by receptor chimeras
11/05/1997	EP0804411A1 Synthetic polyunsaturated fatty acid analogues
11/05/1997	EP0804201A1 Method of treating opportunistic infections with azaspiranes
11/05/1997	EP0432203B1 Legionellosis vaccines and methods for their production
11/04/1997	US5683696 Cloning of duffy blood group antigen, gpD
10/1997
10/30/1997	WO1997040058A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/30/1997	CA2252581A1 Flea protease proteins, nucleic acid molecules, and uses thereof
10/29/1997	EP0803192A1 Antimycotic ectoparasiticidal product for external use
10/28/1997	US5681724 Parasitic helminth macrophage inhibitory factor nucleic acid molecules and uses thereof
10/23/1997	WO1997038966A2 Cytoprotective compounds
10/23/1997	WO1997038695A1 Dhea combination therapy
10/23/1997	WO1997031019A3 Antipathogenic peptides and compositions comprising them
10/23/1997	WO1997030158A3 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
10/23/1997	CA2251733A1 Dhea combination therapy
10/22/1997	CN1162446A Bathing preparation for pets against diseases and method for preparation
10/16/1997	WO1997038084A2 Polynucleotides derived from a pbmc cdna library encoding secreted proteins
10/16/1997	WO1997024138A3 Medical use of proteases
10/16/1997	CA2250860A1 Polynucleotides encoding secreted proteins
10/14/1997	US5677438 Polynucletide sequence
10/14/1997	US5677332 Avermectin or milbemycins
10/14/1997	US5677331 Antimalarial compositions
10/14/1997	US5676953 Intestinal protozoal vaccines
10/09/1997	WO1997036932A1 Modified/chimeric superantigens and their use
10/09/1997	WO1997036590A1 8-aminoquinolines
10/09/1997	WO1997036582A1 Use of substituted aryl imidazoles
10/09/1997	WO1997036581A1 Photopheresis treatment of leukocytes
10/09/1997	WO1997036485A1 Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/09/1997	DE19613172A1 Verwendung von substituierten Aryl-imidazolen Use of substituted aryl imidazoles
10/09/1997	CA2250507A1 Use of substituted aryl imidazoles
10/08/1997	EP0584222B1 Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
10/07/1997	US5674858 Medicaments for treating gastrointestinal disorders
10/07/1997	US5674537 Electrolyzed saline solution containing concentrated amounts of ozone and chlorine species
10/07/1997	US5674484 Vaccine antigens for treatment of poultry
10/02/1997	WO1997035619A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/02/1997	WO1997035572A1 Carboxylic acid indole inhibitors of chemokines
10/02/1997	WO1997035538A2 Tumor necrosis factor alpha convertase
10/02/1997	CA2249985A1 Tumour necrosis factor alpha convertase
10/02/1997	CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen
10/01/1997	EP0797579A1 Erythromycin a 9-0-oxime derivatives endowed with antibiotic activity
10/01/1997	CN1035986C Process for preparing composition of sustained release bolus
09/1997
09/30/1997	US5672697 Form oligonucleotides stable to nuclease degradation
09/30/1997	CA1339481C Anthelmintic bioconversion products
09/30/1997	CA1339480C Antiparasitic agents and process for their preparation
09/25/1997	WO1997034911A1 Apoptosis inducing molecule ii
09/25/1997	WO1997034897A1 Fused imidazole derivatives as multidrug resistance modulators
09/25/1997	CA2248868A1 Apoptosis inducing molecule ii
09/24/1997	EP0796841A1 Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity
09/23/1997	US5670496 Treatment for toxoplasmosis with a composition comprising a folate antagonist and a spiropiperidyl derivative of rifamycin S
09/23/1997	US5670485 Anticoccidial methods and feedstuffs
09/18/1997	WO1997033999A1 Immunity to trypanosomatids species
09/18/1997	WO1997033919A1 Thioureido-cyclodextrins particularly useful for solubilising antitumoral and antiparasitic agents, and methods for preparing same
09/18/1997	WO1997033883A1 Novel pyrimidine compounds useful in treating cytokine mediated diseases
09/18/1997	WO1997033602A1 Peptides with increased binding affinity for hla molecules
09/18/1997	CA2248684A1 Immunity to trypanosomatids species
09/18/1997	CA2248657A1 Peptides with increased binding affinity for hla molecules
09/17/1997	EP0794787A1 Compositions for the treatment of parasitic and fungal infections
09/17/1997	EP0537280B1 Preparation and use of transfer factor
09/17/1997	CN1159831A Vaccines containing borrelia burgdorferi OSPG
09/17/1997	CN1159760A Enteral vaccine for vaginal infections
09/16/1997	US5668130 Medicament for treating gastrointestinal disorders
09/16/1997	US5668105 Aza cyclohexapeptide compounds
09/10/1997	EP0674649B1 Antiparasitic agents
09/10/1997	CN1158855A Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmacueticals
09/09/1997	US5665708 Process and antiparasitic intermediates for doramectin
09/09/1997	US5665707 Treatment for toxoplasmosis with a composition comprising a lincosamide and a spiropiperidyl derivative of rifamycik S
09/03/1997	EP0792365A1 Immunogens for stimulating mucosal immunity
09/03/1997	EP0792278A1 Tumor necrosis factor-gamma
09/03/1997	EP0792271A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum
09/02/1997	US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups
09/02/1997	US5663201 Complexes with iron or aluminum
09/02/1997	US5663140 Parasiticides for humans and livestock
09/02/1997	US5662910 Antiprotozoa
08/1997
08/28/1997	WO1997031019A2 Antipathogenic peptides and compositions comprising them
08/28/1997	CA2247025A1 Antipathogenic peptides and compositions comprising them
08/27/1997	EP0790988A1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
08/27/1997	EP0790833A1 Process for identifying para cation channel modulators
08/27/1997	EP0625967B1 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines

1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 218